Skip to content
PubMed This is a summary of 9 peer-reviewed journal articles Updated
Endocrinology

GH vs IGF-1 in Acromegaly: What is the Difference?

At a Glance

Doctors test IGF-1 instead of Growth Hormone (GH) for acromegaly because GH is released in rapid, unpredictable bursts. In contrast, the liver produces IGF-1 steadily in response to overall GH levels, providing a much more reliable and accurate measure of average hormone activity over time.

Your doctor checks your IGF-1 (Insulin-like Growth Factor 1) levels rather than just relying on Growth Hormone (GH) because of how differently these two hormones behave in your blood. GH is released in rapid bursts throughout the day, making a single blood draw unreliable [1][2]. In contrast, IGF-1 is produced by your liver in a slow, steady response to GH, giving your doctor a reliable, stable picture of your average hormone activity over time [3][4].

The GH-IGF-1 Axis Explained

To understand your lab work, it helps to look at the GH-IGF-1 axis—the communication pathway between your brain and your liver [5].

  • The Pituitary Gland: In acromegaly, a benign tumor (adenoma) in this gland produces excess Growth Hormone [3].
  • The Liver: Your liver receives the GH signal and produces IGF-1 in response [3].
  • The Body: IGF-1 is the hormone that actually causes most of the physical growth, as well as the metabolic changes (like insulin resistance), associated with acromegaly [4].

Why Random Growth Hormone Tests Are Unreliable

Growth Hormone secretion follows a pulsatile pattern [1]. This means your pituitary gland releases it in sharp bursts or pulses, followed by periods where the hormone drops to almost zero [6].

Because GH has a very short lifespan in the blood, a random blood test only captures a single moment in time [2]. These tricky testing dynamics are one of the reasons many patients go years without a proper diagnosis.

  • The risk of false negatives: You could have active acromegaly, but if the blood is drawn between hormone pulses, your GH levels might look completely normal [7].
  • The risk of false positives: A healthy person without acromegaly could have blood drawn right at the peak of a normal pulse, falsely suggesting their levels are too high [2].

Why IGF-1 Is the Reliable Standard

Because IGF-1 is produced steadily in response to total GH levels, it does not spike or crash during the day [3]. It acts as a continuous, time-integrated marker of your overall growth hormone activity [4].

Think of Growth Hormone like a flickering lightbulb—sometimes it is blindingly bright, and sometimes it is briefly off. IGF-1 is like the electric bill at the end of the month that accurately tells you exactly how much energy was used overall. This stability makes IGF-1 the preferred hormone for diagnosing acromegaly and monitoring how well your treatment is working over time [2].

Important Note on Normal Ranges: Natural IGF-1 levels decline as we get older. When your doctor checks your labs, they must compare your result against an age-matched reference range. A number that looks normal for a 20-year-old might actually be dangerously high for a 50-year-old. Always ensure your results are being evaluated against the correct range for your age group [4].

When Might Growth Hormone Still Be Tested?

While random GH tests are rarely helpful, doctors do sometimes test GH in a specific, controlled setting called an oral glucose tolerance test (OGTT) or glucose suppression test [3].

Normally, consuming a large amount of sugar (glucose) triggers the body to temporarily stop producing GH. If you consume a glucose drink and your GH levels remain elevated, it confirms that a pituitary tumor is ignoring the body’s normal ‘off’ switch [3].

Factors That Can Affect Your Results

While IGF-1 is a reliable marker, certain other conditions and medications can falsely lower the result, meaning your IGF-1 might look normal even if your GH is too high [8]. These include:

  • Oral estrogen (such as birth control pills or hormone replacement therapy), which can mask active tumor growth [5]
  • Uncontrolled diabetes [9]
  • Liver or kidney disease [8]
  • Severe malnutrition [9]

Because the GH-IGF-1 relationship is complex, your care team will always interpret your lab results alongside your physical symptoms and MRI imaging rather than relying solely on a single blood test [5][4].

Common questions in this guide

Why do doctors test IGF-1 instead of Growth Hormone for acromegaly?
Growth hormone is released in unpredictable bursts throughout the day, making a random test unreliable. Your liver produces IGF-1 in a slow, steady response to total growth hormone levels. This makes IGF-1 a much more stable and accurate measure of your overall hormone activity.
What is an oral glucose tolerance test (OGTT) for acromegaly?
An OGTT is a specific test where you consume a sugary drink to see how your body reacts. Normally, high blood sugar causes the body to stop producing growth hormone. If your growth hormone levels remain high after the drink, it helps confirm a pituitary tumor.
Do normal IGF-1 levels change based on my age?
Yes, natural IGF-1 levels decline as you get older. Doctors must compare your lab results against an age-matched reference range to determine if your levels are too high. A normal result for a young adult could be dangerously high for an older adult.
Can medications affect my IGF-1 test results?
Yes, certain medications like oral estrogen found in birth control pills or hormone replacement therapy can falsely lower your IGF-1 results. This can mask active tumor growth, even if your growth hormone levels are too high. Uncontrolled diabetes and liver disease can also affect the results.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What is the specific age-adjusted target range for my IGF-1 levels?
  2. 2.Are any of my current medications, such as oral estrogens, potentially masking my true IGF-1 levels?
  3. 3.How frequently will we need to check my IGF-1 levels to monitor my treatment progress?
  4. 4.Given my symptoms and IGF-1 results, do we need to perform an oral glucose tolerance test (OGTT) to confirm my diagnosis?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (9)
  1. 1

    Neuroendocrine circuit for sleep-dependent growth hormone release.

    Ding X, Hwang FJ, Silverman D, et al.

    Cell 2025; (188(18)):4968-4979.e12 doi:10.1016/j.cell.2025.05.039.

    PMID: 40562026
  2. 2

    "Micromegaly": an update on the prevalence of acromegaly with apparently normal GH secretion in the modern era.

    Butz LB, Sullivan SE, Chandler WF, Barkan AL

    Pituitary 2016; (19(6)):547-551 doi:10.1007/s11102-016-0735-0.

    PMID: 27497970
  3. 3

    A Long-Term Follow-Up of 2 Cases of Subclinical Acromegaly.

    Babu HM, Hoang TD, Spiro AJ, et al.

    AACE endocrinology and diabetes 2025; (12(1)):15-18 doi:10.1016/j.aed.2025.02.003.

    PMID: 40677800
  4. 4

    The Biochemical Diagnosis of Acromegaly.

    Akirov A, Masri-Iraqi H, Dotan I, Shimon I

    Journal of clinical medicine 2021; (10(5)) doi:10.3390/jcm10051147.

    PMID: 33803429
  5. 5

    The ongoing challenge of discrepant growth hormone and insulin-like growth factor I results in the evaluation of treated acromegalic patients: a systematic review and meta-analysis.

    Kanakis GA, Chrisoulidou A, Bargiota A, et al.

    Clinical endocrinology 2016; (85(5)):681-688 doi:10.1111/cen.13129.

    PMID: 27292418
  6. 6

    Rhythmic growth hormone secretion in physiological and pathological conditions: Lessons from rodent studies.

    Huang L, Huang Z, Chen C

    Molecular and cellular endocrinology 2019; (498()):110575 doi:10.1016/j.mce.2019.110575.

    PMID: 31499134
  7. 7

    Suspected silent pituitary somatotroph neuroendocrine tumor associated with acromegaly-like bone disorders: a case report.

    Xiao T, Mao X, Wang O, et al.

    BMC endocrine disorders 2024; (24(1)):121 doi:10.1186/s12902-024-01657-7.

    PMID: 39044175
  8. 8

    Acromegaly presenting with low insulin-like growth factor-1 levels and diabetes: a case report.

    Wijayaratne DR, Arambewela MH, Dalugama C, et al.

    Journal of medical case reports 2015; (9()):241 doi:10.1186/s13256-015-0736-z.

    PMID: 26514337
  9. 9

    Mini Review/Commentary: Growth Hormone Treatment in Children with Type 1 Diabetes.

    Bonfig W, Holl RW

    International journal of molecular sciences 2019; (20(3)) doi:10.3390/ijms20030772.

    PMID: 30759741

This page explains hormone testing for acromegaly for educational purposes only. Always consult your endocrinologist to accurately interpret your specific IGF-1 and GH lab results.

Get notified when new evidence is published on Acromegaly.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.